BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8877643)

  • 1. Hepatic amyloidosis presenting with severe intrahepatic cholestasis.
    Goenka MK; Bhasin DK; Vasisth RK; Dhawan S
    J Clin Gastroenterol; 1996 Sep; 23(2):134-6. PubMed ID: 8877643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary systemic amyloidosis with giant hepatomegaly and a swiftly progressive course.
    Mainenti PP; Petrelli G; Lamanda R; Amalfi G; Castiglione F
    J Clin Gastroenterol; 1997 Apr; 24(3):173-5. PubMed ID: 9179738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver.
    Melkebeke P; Vandepitte J; Hannon R; Fevery J
    Digestion; 1980; 20(5):351-7. PubMed ID: 7390060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic amyloidosis manifesting severe intrahepatic cholestasis.
    Kitamura Y; Yokomori H
    Intern Med; 2005 Jun; 44(6):675-6. PubMed ID: 16020906
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloma and severe cholestasis.
    Licht A; Maurer R; Oelz O
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1201-4. PubMed ID: 10486860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal hypertension and intrahepatic cholestasis in primary amyloidosis.
    Çağlar E; Özbay G; Kalyon H; Sonsuz A
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():258-9. PubMed ID: 25910329
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary amyloidosis presenting as intrahepatic cholestasis.
    Bandyopadhyay SK; Bandyopadhyay R; Dutta A
    Indian J Pathol Microbiol; 2006 Oct; 49(4):557-9. PubMed ID: 17183853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primarily isolated hepatic involvement of amyloidosis: A case report and overview.
    Ye L; Shi H; Wu HM; Wang FY
    Medicine (Baltimore); 2016 Dec; 95(52):e5645. PubMed ID: 28033255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe intrahepatic cholestasis, erythrocytosis and hypoglycemia: unusual presenting features of systemic AL amyloidosis.
    Ferreira S; Baldaia C; Fatela N; Ramalho F; Costa MA; Brito D; Esteves G; Monteiro E
    Scand J Gastroenterol; 2008 Mar; 43(3):375-9. PubMed ID: 18938770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different morphologic aspects and clinical features in massive hepatic amyloidosis.
    Melato M; Manconi R; Magris D; Morassi P; Benussi DG; Tiribelli C
    Digestion; 1984; 29(3):138-45. PubMed ID: 6745505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis.
    Dohmen K; Nagano M; Iwakiri R; Yamano Y; Kikuchi Y; Mizoguchi M; Iwata Y; Mori Y; Ishibashi H
    Gastroenterol Jpn; 1991 Jun; 26(3):376-81. PubMed ID: 1889693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary amyloidosis of the gastrointestinal tract and liver--two case reports].
    Halm U; Berr F; Eggers E; Wohlgemuth B; Mössner J
    Z Gastroenterol; 1997 Feb; 35(2):131-7. PubMed ID: 9163226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe recurrent intrahepatic cholestasis in systemic AL amyloidosis without obvious liver involvement: unexplained hepatic toxicity or a case of misdiagnosed liver amyloidosis?].
    Paudice N; Farsetti S; Caroti L; Bandini S; Ciuti G; Tempestini A; Perfetto F; Galli S; Giabbani L; Caldini AL; Bergesio F
    G Ital Nefrol; 2012; 29(1):92-7. PubMed ID: 22388910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrahepatic obstructive jaundice due to amyloidosis of the liver. A case report and review of the literature.
    Levy M; Fryd CH; Eliakim M
    Gastroenterology; 1971 Aug; 61(2):234-8. PubMed ID: 5314952
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case report of systematic amyloid with hepatic function abnormal].
    Cao LL; Zhao B; Lai W; Luo ZG; Chen XP
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):71. PubMed ID: 20128978
    [No Abstract]   [Full Text] [Related]  

  • 16. AL-type amyloidosis presenting with rapidly deteriorating liver involvement.
    Linardaki G; Drivas G; Archimandritis A
    J Clin Gastroenterol; 1997 Jun; 24(4):297-8. PubMed ID: 9252870
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary amyloidosis presenting with cholestasis and hyperkinetic portal hypertension.
    Culafić D; Perisić M; Boricić I; Culafić-Vojinović V; Vukcević M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):201-4. PubMed ID: 17592572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging with liver-specific contrast agent in primary amyloidosis and intrahepatic cholestasis.
    Møller JM; Santoni-Rugiu E; Chabanova E; Løgager V; Hansen AB; Thomsen HS
    Acta Radiol; 2007 Mar; 48(2):145-9. PubMed ID: 17354133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic amyloidosis presenting as severe intrahepatic cholestasis: a case report and review of the literature.
    Hoffman MS; Stein BE; Davidian MM; Rosenthal WS
    Am J Gastroenterol; 1988 Jul; 83(7):783-5. PubMed ID: 3289380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striking cholestatic liver disease: a distinct manifestation of advanced primary amyloidosis.
    Rockey DC
    South Med J; 1999 Feb; 92(2):236-41. PubMed ID: 10071676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.